DRMAW
Dermata Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−50.00%Aug 25, 2026, 12:30 UTC
Dermata Therapeutics announced the commercial launch of its Tome Foundational Treatment skincare product, now available for purchase on its website.
Source:Aug 17, 2026, 00:00 UTC
Dermata Therapeutics, Inc. signed a private placement agreement on August 18, 2026, to raise approximately $3.4 million in gross proceeds through the sale of common stock, pre-funded warrants, Series E warrants, and Series F warrants.
Aug 11, 2026, 20:05 UTC
Dermata Therapeutics announced the launch date of its first commercial product, Tome Foundational Treatment, expected on August 25, 2026.
Source:Aug 5, 2026, 12:30 UTC
Dermata Therapeutics announced that its first direct-to-consumer skincare product, Tome Foundational Treatment, is planned to launch on August 25, 2026, with waitlist members getting early access to preorder.